<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:st1="urn:schemas-microsoft-com:office:smarttags"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="remote_control_files/filelist.xml">
<title>Untitled Document</title>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="PlaceName"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="PlaceType"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="State"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="City"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
 name="place"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>ILPB User</o:Author>
  <o:LastAuthor>ILPB User</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2008-09-26T21:04:00Z</o:Created>
  <o:LastSaved>2008-09-26T21:07:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>781</o:Words>
  <o:Characters>4458</o:Characters>
  <o:Company>University at Buffalo</o:Company>
  <o:Lines>37</o:Lines>
  <o:Paragraphs>10</o:Paragraphs>
  <o:CharactersWithSpaces>5229</o:CharactersWithSpaces>
  <o:Version>11.9999</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal>Release Date 06/06/06 <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><st1:City w:st="on">BUFFALO</st1:City>, <st1:State w:st="on">N.Y.</st1:State>
-- A <span class=SpellE>nanoparticle</span>-based drug delivery concept in
which an applied magnetic field directs the accumulation in tumor cells of
custom-designed, drug-filled <span class=SpellE>nanocarriers</span> has been
demonstrated by University at <st1:City w:st="on"><st1:place w:st="on">Buffalo</st1:place></st1:City>
researchers. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The new approach, recently published in Molecular
Pharmaceutics, may lead to treatments that exploit the advantages of
photodynamic therapy (PDT) and that have the potential to reduce drug
accumulation in normal tissues. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The in vitro results showed that magnetically guided
delivery to tumor cells of these customized <span class=SpellE>nanocarriers</span>
allowed for more precise targeting, while boosting cellular uptake of the PDT
drugs contained inside them. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;This is a novel way to enhance drug delivery to
cells,&quot; said <span class=SpellE>Paras</span> Prasad, Ph.D., executive
director of <span class=SpellE>UB's</span> Institute for Lasers, Photonics and <span
class=SpellE>Biophotonics</span>, SUNY Distinguished Professor in the
Department of Chemistry in the UB College of Arts and Sciences and co-author on
the paper. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;The externally applied magnetic field acted as a kind
of 'remote control,' directing the <span class=SpellE>nanocarriers</span> to
the targeted area in the cell culture,&quot; he said. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Once the magnetic field was applied, the concentration of
drug inside the tumor cells in the target area increased. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;We have shown that we can use <span class=SpellE>magnetophoretic</span>
control to deliver PDT drug to tumor cells, resulting in increased accumulation
inside those cells,&quot; explained <span class=SpellE>Tymish</span> <span
class=SpellE>Ohulchanskyy</span>, Ph.D., senior research scientist in the
Department of Chemistry. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The research was conducted with partial funding from <span
class=SpellE>UB's</span> New York State Center of Excellence in Bioinformatics
and Life Sciences, which is a major supporter of the <span class=SpellE>nanomedicine</span>
program at the Institute for Lasers, Photonics and <span class=SpellE>Biophotonics</span>.
Prasad is affiliated with the Bioengineering/Tissue Engineering Team at the <st1:place
w:st="on"><st1:PlaceType w:st="on">Center</st1:PlaceType> of <st1:PlaceName
 w:st="on">Excellence</st1:PlaceName></st1:place>. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;The <span class=SpellE>nanomedicine</span> work by Dr.
Prasad and his team has far-reaching implications for a variety of disease
areas, including neurological disease and cardiac disease,&quot; said Bruce A. Holm,
UB senior vice provost and executive director of the <st1:place w:st="on"><st1:PlaceType
 w:st="on">Center</st1:PlaceType> of <st1:PlaceName w:st="on">Excellence</st1:PlaceName></st1:place>.
&quot;The institute represents a key partner with the <st1:place w:st="on"><st1:PlaceType
 w:st="on">Center</st1:PlaceType> of <st1:PlaceName w:st="on">Excellence</st1:PlaceName></st1:place>.&quot;
<o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>According to Prasad, photodynamic therapy is one of the most
promising treatments for cancer; it's also being investigated as a treatment
method for cardiovascular, dermatological and ophthalmic diseases. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>PDT exploits the propensity of tumors to retain higher
concentrations of photosensitive drugs than normal tissues. When exposed to
laser light, these drugs generate toxic molecules that destroy the cancer
cells. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The main side effect associated with photodynamic cancer
therapy is the patient's strong sensitivity to light for four to six weeks
after treatment, a result of PDT drugs that accumulate in the skin. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;The magnetically guided drug delivery would allow for
the use of lower concentrations of the drug to deliver a therapeutic dose, thus
significantly reducing the amount of PDT drug that accumulates in normal
tissue,&quot; said Prasad. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The UB team achieved these results with a novel <span
class=SpellE>nanocarrier</span> system, developed from polymer micelles, which
are <span class=SpellE>nanosized</span>, water-dispersible clusters of
polymeric molecules. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Prasad explained that polymeric micelles are excellent <span
class=SpellE>nanocarriers</span> for PDT drugs, which are mostly
water-insoluble. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Along with the photodynamic drug, the UB researchers
encapsulated inside the <span class=SpellE>nanocarriers</span> iron oxide <span
class=SpellE>nanoparticles</span>, which allowed them to respond to externally
applied magnetic fields. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>In the experiments, <span class=SpellE>nanocarriers</span>
were shown to be efficiently taken up by cultured tumor cells in the area
exposed to the magnetic field, as demonstrated by <span class=SpellE>confocal</span>
microscopy. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>While the team has demonstrated this concept with PDT drugs,
Prasad said the technique would be useful in delivering gene therapy,
chemotherapy or practically any kind of pharmaceutical treatment into cells. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>&quot;Because the <span class=SpellE>nanocarriers</span>
proved to be significantly stable and because they retained the PDT drugs, we
are optimistic that they will be able to deliver a wide range of therapies to
tumors or other disease sites in the body without any significant loss in the
circulatory system or in normal tissues,&quot; said Prasad. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The team is beginning in vivo studies on the new
drug-delivery method. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Preliminary studies in live animals have indicated that an
applied magnetic field can effect a localized accumulation in the tumor site,
according to Earl J. <span class=SpellE>Bergey</span>, Ph.D., deputy director
of <span class=SpellE>biophotonics</span> at the UB institute and a co-author
on the paper. <o:p></o:p></p>

<p class=MsoNormal><o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Other co-authors are <span class=SpellE>Ludmila</span> O. <span
class=SpellE>Cinteza</span>, Ph.D., former post-doctoral researcher at the
institute; <span class=SpellE>Ravindra</span> K. <span class=SpellE>Pandey</span>,
Ph.D., professor of biophysical sciences at the Roswell Park Cancer Institute
and research professor at the institute and <span class=SpellE>Yudhisthira</span>
<span class=SpellE>Sahoo</span>, Ph.D., research assistant professor in the UB
Department of Chemistry. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>The UB research was funded by the John R. <span
class=SpellE>Oishei</span> Foundation, <span class=SpellE>UB's</span> New York
State Center of Excellence in Bioinformatics and Life Sciences and by the UB
Interdisciplinary Research and Creative Activities Fund. New York State Sen.
Mary Lou <span class=SpellE>Rath</span> also has provided generous support to <span
class=SpellE>UB's</span> Institute for Lasers, Photonics and <span
class=SpellE>Biophotonics</span>. <o:p></o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
